Content about New Drugs & OTCs

October 11, 2013

Neat Feat Baby B Diaper Cream is a preventive cream that helps treat the cause of the rash and restores the normal environment of the skin, according to the company.

LOS ANGELES — Neat Feat Baby B Diaper Cream is a preventive cream that helps treat the cause of the rash and restores the normal environment of the skin, according to the company. 

The product also inhibits growth of fungi that contributes to skin irritation and reduces excess moisture, promoting a more natural Ph balance for the skin, the company stated.

BabyB Baby Saver Cream is part of Neat Feat's new Body Saver range. 

October 10, 2013

A new strength of a drug for athlete's foot made by Merz Pharma Group has become available, the company said Thursday.

GREENSBORO, N.C. — A new strength of a drug for athlete's foot made by Merz Pharma Group has become available, the company said Thursday.

Merz, the U.S. affiliate of Germany-based Merz Pharma Group, announced the nationwide availability of Naftin (naftifine hydrochloride) gel in the 2% strength, a topical treatment for the foot fungus infection known medically as tinea pedis. The company called the new drug an improvement on the original 1% Naftin.

October 9, 2013

The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

SILVER SPRING, Md. — The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

October 8, 2013

The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

The FDA announced the approval of Duavee (conjugated estrogens; bazedoxifene), made by Pfizer. The drug is for women who suffer from moderate to severe hot flashes associated with menopause, and is also designed to prevent osteoporosis after menopause.

October 8, 2013

GreenLight Rx is offering a line of medicine bottles aimed at elderly people and those suffering from such conditions as arthritis, the company said.

SANTA ANA, Calif. — GreenLight Rx is offering a line of medicine bottles aimed at elderly people and those suffering from such conditions as arthritis, the company said.

October 8, 2013

Topical BioMedics recently announced distribution through CVS/pharmacy for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics.

RHINEBECK, N.Y. — Topical BioMedics recently announced distribution through CVS/pharmacy for its Topricin Foot Therapy Cream, a homeopathic topical treatment for pain associated with fibromyalgia and neuropathy that is safe for diabetics.

October 4, 2013

Humidifiers help provide temporary relief from cough and congestion, counteract the effects of harsh, dry air, and can bring temporary relief to dry skin, stuffy noses and chapped lips — the three most irritating wintertime ailments, according to a new survey of U.S. moms, conducted by the makers of Vicks humidifiers.

SOUTHBOROUGH, Mass. — Humidifiers help provide temporary relief from cough and congestion, counteract the effects of harsh, dry air, and can bring temporary relief to dry skin, stuffy noses and chapped lips — the three most irritating wintertime ailments, according to a new survey of U.S. moms, conducted by the makers of Vicks humidifiers. 

October 2, 2013

DSN visited the Baltimore Convention Center last week to check out the Natural Products Expo East. DSN reviews its top 10 new products from the show.

BALTIMORE — DSN visited the Baltimore Convention Center last week to check out the Natural Products Expo East. DSN reviews its top 10 new products from the show. 

The products identified below all have curb appeal, meaning they look like they'd fit in on a mass merchant's shelf and may serve a niche customer base that's shopping food, drug and mass outlets but not buying these specialty items, necessarily. 

October 1, 2013

The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

The FDA announced the approval of Brintellix (vortioxetine) tablets for treating MDD in adults. The drug will be available in the 5-mg, 10-mg, 15-mg and 20-mg strengths.

October 1, 2013

Generic drug maker Teva Pharmaceutical Industries has launched a version of a drug used to treat a parathyroid disorder related to kidney disease.

JERUSALEM — Generic drug maker Teva Pharmaceutical Industries has launched a version of a drug used to treat a parathyroid disorder related to kidney disease.

Teva announced Tuesday the launch of paricalcitol, a generic version of AbbVie's Zemplar. As the first company to win Food and Drug Administration approval for the drug, Teva has 180 days in which to compete directly with the branded version.

September 30, 2013

Envy Medical has expanded its ClarityMD line with the new Clarifying Acne Treatment Pads made with a gentle, alcohol-free formula that soothes skin with aloe.

WESTLAKE VILLAGE, Calif. — Envy Medical has expanded its ClarityMD line with the new Clarifying Acne Treatment Pads made with a gentle, alcohol-free formula that soothes skin with aloe.

September 30, 2013

The Food and Drug Administration has approved a drug for treating early-stage breast cancer before surgery, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for treating early-stage breast cancer before surgery, the agency said Monday.

September 30, 2013

The Food and Drug Administration has approved a new usage for a drug made by UCB, the drug maker said Monday.

BRUSSELS — The Food and Drug Administration has approved a new usage for a drug made by UCB, the drug maker said Monday.

UCB announced the approval of Cimzia (certolizumab pegol) for psoriatic arthritis in adults. Psoriatic arthritis is an inflammatory, autoimmune condition that causes pain, swelling and stiffness around the joints, usually combined with the skin lesions of psoriasis. The drug was already approved to treat rheumatoid arthritis and Crohn's disease.

September 30, 2013

Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

PITTSBURGH — Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

The drug maker announced the launch of voriconazole for oral suspension in the 40-mg-per-mL strength. The drug is the first generic version of Pfizer's Vfend, and as the first company to receive approval for a generic version, Mylan has 180 days in which to compete exclusively against Pfizer's product. The drug is used to treat invasive fungal infections.

September 27, 2013

ScriptPro's Central Pharmacy Management System Point of Sale can now interface with a real-time system for tracking and controlling OTC products that can be used to manufacture methamphetamine.

MISSION, Kan. — ScriptPro's Central Pharmacy Management System Point of Sale can now interface with a real-time system for tracking and controlling OTC products that can be used to manufacture methamphetamine.

ScriptPro said its system now interfaces with the Appriss National Precursor Log Exchange system, currently used by pharmacies and law enforcement agencies in 22 states to track products like pseudoephedrine-based cold and allergy remedies. ScriptPro said the interface eliminates the need to keep a manual log to document sales of the products.

September 26, 2013

Parents in its October issue will feature the True Easy Syringe from Health Enterprises as the simple way “to give your child the correct dose of liquid medicine.”

NORTH ATTLEBORO, Mass. — Parents in its October issue will feature the True Easy Syringe from Health Enterprises as the simple way “to give your child the correct dose of liquid medicine.”

The patented True Easy Syringe was designed by a mother of three children to make it easy to give accurate doses of medicine. The new product features a patented two-step color coded dosing system and oversized grip for ease of use.

September 26, 2013

Merck Consumer Care announced that Oxytrol for Women is now on shelf for the more than 20 million women suffering from overactive bladder.

WHITEHOUSE STATION, N.J. — Merck Consumer Care on Wednesday announced that Oxytrol for Women is now on shelf for the more than 20 million women suffering from overactive bladder. Oxytrol for Women is a thin, flexible patch that is discreetly applied to the abdomen, hip or buttock once every four days for the relief of overactive bladder in women. It is the first and only over-the-counter option that treats the OAB symptoms — urinary incontinence, urgency and frequency — which can take a physical and emotional toll on women.

September 26, 2013

Pharmagen on Thursday announced the launch of Clotamin, a unique multivitamin formulated without vitamin K in order to meet the special nutritional needs of people taking blood-thinning medications (anticoagulants), such as Warfarin.

SILVER SPRING, Md. — Pharmagen on Thursday announced the launch of Clotamin, a unique multivitamin formulated without vitamin K in order to meet the special nutritional needs of people taking blood-thinning medications (anticoagulants), such as Warfarin. 

Because it does not contain vitamin K, Clotamin can be taken with Warfarin without affecting international normalized ratio levels. 

September 25, 2013

Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.

PITTSBURGH — Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.

Mylan said Wednesday that Forest Labs and Royalty Pharma had sued it in the U.S. District Court for the District of Delaware in connection with its filing of a regulatory approval application with the Food and Drug Administration for milnacipran hydrochloride tablets in the 12.5-mg, 25-mg, 50-mg and 100-mg strengths. The drug is a generic version of Savella.

September 25, 2013

Oceans Omega on Wednesday announced the launch of Omega-3 fortified liquid health shots. Currently sold under the Omega Infusion brand, the 2-oz., single-serving and zero-calorie health shots contain 250 mg of omega-3s (EPA and DHA).

PARAMUS, N.J. — Oceans Omega on Wednesday announced the launch of Omega-3 fortified liquid health shots. Currently sold under the Omega Infusion brand, the 2-oz., single-serving and zero-calorie health shots contain 250 mg of omega-3s (EPA and DHA).  

They will be available in three flavors, including peach mango, raspberry lemon and pink grapefruit. 

Research shows that consumers are actively looking for Omega-3 fortified food and beverages, the company stated.

September 24, 2013

Abbott on Tuesday introduced a new nutrition shake called Glucerna Advance — formulated for people with diabetes who are seeking additional nutrition and health benefits.

ABBOTT PARK, Ill. — Abbott on Tuesday introduced a new nutrition shake called Glucerna Advance — formulated for people with diabetes who are seeking additional nutrition and health benefits. The new product helps to minimize blood sugar spikes while supporting heart hearth and the immune system, Abbott noted. 

September 24, 2013

Belgian drug maker Ablynx is licensing an experimental treatment for rheumatoid arthritis and lupus to U.S. drug maker AbbVie in a deal worth up to $840 million.

GHENT, Belgium — Belgian drug maker Ablynx is licensing an experimental treatment for rheumatoid arthritis and lupus to U.S. drug maker AbbVie in a deal worth up to $840 million, the companies said.

The two drug makers announced that AbbVie would license the drug ALX-0061 for an upfront payment of $175 million plus milestone payments worth up to $665 million, as well as royalties. The drug belongs to a class known as anti-interleukin-6R nanobodies, which work by targeting an immune-system protein pathway that plays a key role in the inflammation associated with RA.

September 24, 2013

The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

STAMFORD, Conn. — The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

Purdue announced the approval of the 15-microgram-per-hour strength of Butrans (buprenorphine). The drug is used to treat moderate to severe chronic pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. The new strength is in addition to the 5-microgram, 10-microgram and 20-microgram strengths already on the market, and it will be launched next month.

September 23, 2013

The Food and Drug Administration has approved a drug made by Johnson & Johnson for psoriatic arthritis, the company said Monday.

HORSHAM, Pa. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for psoriatic arthritis, the company said Monday.

Janssen Biotech, a subsidiary of J&J, announced the approval of Stelara (ustekinumab) alone or combined with the common generic drug methotrexate for treating active psoriatic arthritis in adults. According to the National Psoriasis Foundation, the autoimmune disease is estimated to affect more than 2 million people in the United States and is characterized by joint inflammation and psoriasis skin lesions.

September 23, 2013

The Food and Drug Administration has approved a drug made by Perrigo Co. for treating heart disease, the company said Monday.

ALLEGAN, Mich. — The Food and Drug Administration has approved a drug made by Perrigo Co. for treating heart disease, the company said Monday.

The FDA approved Perrigo's nitroglycerin lingual spray in the 400-mcg-per-spray strength. The drug is used to relieve attacks of or prevent angina pectoris due to coronary artery disease.